Literature DB >> 26962354

Primary intraventricular central nervous system lymphoma in an immunocompetent patient.

Vinit Suri1, Venkatesh Mittapalli1, Manish Kulshrestha1, Kaushal Premlani1, S K Sogani1, Kunal Suri1.   

Abstract

We report a young 15-year-old boy with 6 months history of headache, vomiting, and seizure. He underwent septostomy followed by right ventriculoperitoneal shunt for obstructive hydrocephalus and was managed with empirical antituberculosis treatment. Magnetic resonance imaging (MRI) revealed solid, nodular, enhancing masses in bilateral lateral ventricles and 4(th) ventricle. Surgical biopsy from 4(th) ventricular lesion confirmed a B-cell lymphoma. Staging evaluation with MRI positron emission tomography and bone marrow biopsy were normal suggesting an intraventricular primary central nervous system lymphoma.

Entities:  

Keywords:  Intraventricular tumor; immunocompetent; primary central nervous system lymphoma

Year:  2015        PMID: 26962354      PMCID: PMC4770660          DOI: 10.4103/1817-1745.174433

Source DB:  PubMed          Journal:  J Pediatr Neurosci        ISSN: 1817-1745


Introduction

Lymphoma of the central nervous system (CNS) can present with a wide variety of clinical symptoms and imaging findings, which can be challenging for both the clinician as well as the radiologist. Primary CNS lymphoma (PCNSL) is a rare variant of extranodal non-Hodgkin's lymphoma and accounts for 1% of all primary brain tumors. Lesions of PCNSL are almost always found within the brain parenchyma and may be superficial (subpial) or deep-seated (sub ependymal). Intraventricular PCNSL is an extremely rare presentation of PCNSL with = 15 patients described in literature. We present a patient with PCNSL with lesions in bilateral lateral ventricle and in the 4th ventricle.

Case Report

A young 15-year-old boy had a 6 months history of continuous headache, recurrent vomiting, and a single episode of generalized tonic-clonic seizure. Magnetic resonance imaging (MRI) brain initially within 1 month of onset revealed asymmetrical dilation of bilateral lateral ventricles (L > R) for which endoscopic septostomy was performed at another hospital. The patient showed initial improvement for 2–3 weeks followed by recurrence of symptoms of headache and vomiting. Cerebrospinal fluid examination revealed mild pleocytosis with mildly elevated protein, normal sugar, negative acid-fast Bacilli, fungal cultures, and serology. Right ventriculoperitoneal shunt was performed and empirical antitubercular therapy was initiated at this hospital. The patient remained symptomatic with repeated bouts of headache and recurrent vomiting, despite repeated adjustments of shunt pressures by repeated reprogramming of shunt. Repeat MRI brain [Figure 1] revealed focal, nodular, well defined solid enhancing lesions in the right lateral ventricle and 4th ventricle. The patient had neurological decline with decline in sensorium, severe truncal ataxia, dual incontinence, and right gaze palsy with right 7th infra nuclear and 9th and 10th nerve palsy. Posterior fossa craniotomy and decompression of tumor in the 4th ventricle was performed and biopsy revealed round to oval and monomorphic cells with scanty rim of eosinophilic cytoplasm with large and hyperchromatic nucleoli with irregular nuclear membrane. Few mitotic figures were present, and tumor cells are positive for leukocyte common antigen and CD20 and were negative for CD3, synaptophysin, and glial fibrillary acidic protein. The mib1 labeling index was very high (80%), suggestive of non-Hodgkin's lymphoma (diffuse large B-cell type) [Figure 2]. In view of biopsy, further staging was performed with positron emission tomography MRI whole body which revealed metabolically active lesions in 4th ventricle and discrete lesions in bilateral lateral ventricles with no other systemic fluorodeoxyglucose uptake, suggestive of PCNSL. Bone marrow biopsy was normal.
Figure 1

Original magnetic resonance imaging images. (a and b) Flair images showing right lateral ventricular and 4th ventricular hyperintense nodular lesions. (c-e) Contrast enhancing nodular lesions in right lateral ventricle and 4th ventricle

Figure 2

Original histopathology of 4th intraventricular tumor: (a) H and E staining revealed diffuse infiltration by sheets of atypical lymphoid cells. (b) The individual atypical lymphoid cells are moderately pleomorphic with round to oval hyperchromatic nuclei, inconspicuous nucleoli, and moderate amount of eosinophilic cytoplasm. Frequent mitosis is present. (c) Immunohistochemistry done for CD20 showed strong membranous positivity. (d) KI67/MIBI labeling index was very high (almost >80% positivity)

Original magnetic resonance imaging images. (a and b) Flair images showing right lateral ventricular and 4th ventricular hyperintense nodular lesions. (c-e) Contrast enhancing nodular lesions in right lateral ventricle and 4th ventricle Original histopathology of 4th intraventricular tumor: (a) H and E staining revealed diffuse infiltration by sheets of atypical lymphoid cells. (b) The individual atypical lymphoid cells are moderately pleomorphic with round to oval hyperchromatic nuclei, inconspicuous nucleoli, and moderate amount of eosinophilic cytoplasm. Frequent mitosis is present. (c) Immunohistochemistry done for CD20 showed strong membranous positivity. (d) KI67/MIBI labeling index was very high (almost >80% positivity)

Discussion

CNS involvement in lymphoma can be secondary to a systemic lymphoma, which is the most common presentation. Alternatively, there can be isolated involvement of the CNS without any systemic lymphoma, which is the PCNSL variant. Secondary CNS lymphoma is almost always due to non-Hodgkin's lymphoma with spread to CNS which usually occurs after a median of 5–12 months after the primary diagnosis. Two-thirds of such secondary lymphoma infiltration occurs into the leptomeninges, subependymal, dural, or even cranial nerves and one-third present with CNS parenchymal infiltration.[1] PCNSL is a rare variant of extranodal non-Hodgkin's lymphoma and accounts for 1% of all primary brain tumors and is commonly a diffuse large B-cell type. PCNSL is usually associated with an immunodeficiency state, but may also be observed in immunocompetent individuals. As opposed to secondary CNS lymphoma, lesions of PCNSL are almost always found within the brain parenchyma and may be superficial (subpial) or deep-seated (sub ependymal). PCNSL commonly presents within the brain parenchyma in superficial (subpial) or deep-seated (subependymal location). Intraventricular PCNSL is an extremely rare presentation with only few case reports.[2345678] Most of these case reports have described PCNSL occurrence in a single cerebral ventricle except the involvement of right lateral ventricle and 4th ventricle in one report,[9] which is also the presentation of our patient. The imaging features of PCNSL are not characteristic and usually reveals hypo- or iso-intense lesions on T1-weighted MRI, iso- or hyper-intense lesions on T2-weighted images, and lesions show moderate to marked contrast enhancement with variable surrounding edema and hence, diagnosis is established only by a biopsy.[10] Differential diagnosis for intraventricular CNS lesions includes central neurocytomas, meningiomas, ependymomas, choroid plexus papilloma, metastasis, neurocysticercosis, and rarely PCNSL. The role of imaging is in aiding to distinguish from other tumors seen in intraventricular location and the diagnosis of PCNSL is essentially based on biopsy and histopathological examination. It is important that primary B-cell lymphoma should be included in the list of differential diagnosis of intraventricular tumors. The standard treatment for PCNSL is biopsy followed by systemic chemotherapy or with intrathecal chemotherapy.[11] High-dose chemotherapy with autologous stem cell transplant may be utilized in patients with chemoresistance.[12]

Financial support and sponsorship

Nil.

Conflicts of interest

There are no conflicts of interest
  12 in total

1.  [Primary intraventricular non-Hodgkin's lymphoma of the CNS].

Authors:  M Lettau; M Laible
Journal:  Rofo       Date:  2011-12-16

Review 2.  Modern concepts in the biology, diagnosis, differential diagnosis and treatment of primary central nervous system lymphoma.

Authors:  M Deckert; A Engert; W Brück; A J M Ferreri; J Finke; G Illerhaus; W Klapper; A Korfel; R Küppers; M Maarouf; M Montesinos-Rongen; W Paulus; U Schlegel; H Lassmann; O D Wiestler; R Siebert; L M DeAngelis
Journal:  Leukemia       Date:  2011-08-05       Impact factor: 11.528

3.  R-MPV followed by high-dose chemotherapy with TBC and autologous stem-cell transplant for newly diagnosed primary CNS lymphoma.

Authors:  Antonio Omuro; Denise D Correa; Lisa M DeAngelis; Craig H Moskowitz; Matthew J Matasar; Thomas J Kaley; Igor T Gavrilovic; Craig Nolan; Elena Pentsova; Christian C Grommes; Katherine S Panageas; Raymond E Baser; Geraldine Faivre; Lauren E Abrey; Craig S Sauter
Journal:  Blood       Date:  2015-01-07       Impact factor: 22.113

Review 4.  Central nervous system lymphoma: characteristic findings on traditional and advanced imaging.

Authors:  I S Haldorsen; A Espeland; E-M Larsson
Journal:  AJNR Am J Neuroradiol       Date:  2010-07-08       Impact factor: 3.825

5.  Primary isolated lymphoma of the fourth ventricle: case report.

Authors:  C Haegelen; L Riffaud; M Bernard; X Morandi
Journal:  J Neurooncol       Date:  2001-01       Impact factor: 4.130

Review 6.  Magnetic resonance features of primary central nervous system lymphoma in the immunocompetent patient: a pictorial essay.

Authors:  Kelvin K Yap; Tom Sutherland; Elaine Liew; Con J Tartaglia; Mei Pang; Nick Trost
Journal:  J Med Imaging Radiat Oncol       Date:  2012-03-06       Impact factor: 1.735

7.  Atypical presentation of primary central nervous system non-Hodgkin lymphoma in immunocompetent young adults.

Authors:  Joseph T Cheatle; Michele R Aizenberg; Jeffrey S Weinberg; Daniel L Surdell
Journal:  World Neurosurg       Date:  2012-08-07       Impact factor: 2.104

8.  A rare case of vomiting: fourth ventricular B-cell lymphoma.

Authors:  C S Hill; A F Khan; S Bloom; S McCartney; D Choi
Journal:  J Neurooncol       Date:  2008-12-18       Impact factor: 4.130

9.  [Meningitis caused by primary lymphoma of the central nervous system. Report of a case].

Authors:  L C Werneck; Z Hatschbach; A H Mora; E M Novak
Journal:  Arq Neuropsiquiatr       Date:  1977-12       Impact factor: 1.420

10.  Primary high-grade B-cell lymphoma of the choroid plexus.

Authors:  Paolo C Cecchi; Atto Billio; Vito Colombetti; Paolo Rizzo; Umberto M Ricci; Andreas Schwarz
Journal:  Clin Neurol Neurosurg       Date:  2007-10-24       Impact factor: 1.876

View more
  4 in total

Review 1.  Efficacy of endoscopic management of primary central nervous system lymphoma: a multicentric study and literature review.

Authors:  Mario Ganau; Ismail Zaed; Julien Todeschi; Laura Prisco; Helene Cebula; Carmen Bruno; Giorgio Spatola; Gianfranco K I Ligarotti; Raffaele Alessandrello; Marco Fricia; Antonio Romano; Raoul Pop; Seyyid Baloglu; Luciano Savarese; Antonino Scibilia; Beniamino Nannavecchia; Francois Proust; Salvatore Chibbaro
Journal:  J Neurooncol       Date:  2022-07-12       Impact factor: 4.506

Review 2.  Seizures in steroid-responsive encephalopathy.

Authors:  Xin Xu; Aolei Lin; Xuefeng Wang
Journal:  Neurol Sci       Date:  2020-11-21       Impact factor: 3.307

3.  Supracerebellar infratentorial inverted subchoroidal approach to lateral ventricle lesions: Anatomical study and illustrative case.

Authors:  Irakliy Abramov; Xiaochun Zhao; Evgenii Belykh; Michael T Lawton; David Pitskhelauri; Mark C Preul
Journal:  Surg Neurol Int       Date:  2021-02-03

4.  Clinical Features, Diagnosis, and Treatment of Primary Intraventricular Lymphoma: Insights From a Monocentric Case Series.

Authors:  Lidong Cheng; Hongtao Zhu; Jing Wang; Guanghui Wang; Xiaoyu Ma; Kai Zhao; Junwen Wang; Kai Shu
Journal:  Front Neurol       Date:  2022-06-06       Impact factor: 4.086

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.